Ceftobiprole is a novel broad-spectrum cephalosporin antibiotic that has demonstrated significant efficacy in managing infections caused by methicillin-resistant Staphylococcus aureus (MRSA). Its ...

A research team at the University of Arizona College of Medicine–Tucson is developing a drug that works in combination with copper to kill bacteria, including those that cause MRSA, a type of staph ...

Antibiotics' contributions to modern medicine cannot be understated. They have significantly reduced disease-associated mortality and provided unprecedented extensions to human lifespans.

Scientists have discovered the mechanism which allows the superbug Methicillin Resistant Staphylococcus aureus (MRSA) to become highly resistant to antibiotics, paving the way for new approaches to ...

The methicillin-resistant strain of Staphylococcus aureus (MRSA) kills a million people per year globally, making it one of the three deadliest bacteria in humans. This toll is expected to rise ...

MSSA and MRSA are Staphylococcus aureus (S. aureus) bacteria with different resistance patterns. MRSA is resistant to many antibiotics and is more difficult to treat. Both types of bacteria can cause ...

The World Health Organization is warning drug-resistant bacteria, dubbed ‘superbugs’ are on the rise. These bacteria do not respond to the first-line antibiotics often used by clinicians. Other WRAL ...